Results 281 to 290 of about 187,398 (301)
Some of the next articles are maybe not open access.

Redefining Heart Failure With a Reduced Ejection Fraction

JAMA, 2019
Javed, Butler   +2 more
openaire   +2 more sources

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials

Lancet, The, 2020
Faiez Zannad   +2 more
exaly  

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2020
Burkert Pieske   +2 more
exaly  

Heart Failure with Reduced Ejection Fraction (HFrEF)

2023
Lauren Eyadiel, Bridget Rasmussen
openaire   +1 more source

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

New England Journal of Medicine, 2022
John J V Mcmurray   +2 more
exaly  

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

Lancet, The, 2022
Kieran F Docherty   +2 more
exaly  

Developments in Heart Failure With Reduced Ejection Fraction—Reply

JAMA, 2020
Sean P, Murphy   +2 more
openaire   +2 more sources

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials

Lancet, The, 2020
Muthiah Vaduganathan   +2 more
exaly  

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine, 2019
Catherine M Viscoli   +2 more
exaly  

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study

Lancet, The, 2016
Francisco Campelo-Parada   +2 more
exaly  
heart failure with preserved ejection fraction
humans
stroke volume
3. good health
male
ventricular dysfunction, left
female
prognosis
aged
previous   27  28  29  30  31  

Home - About - Disclaimer - Privacy